Literature DB >> 14506427

Amniotic membrane for repair of exposed hydroxyapatite orbital implant.

Matthew W Lee-Wing1.   

Abstract

Exposure of a hydroxyapatite orbital implant measuring 10 x 3 mm developed in a 25-year-old man. The exposure was repaired with an amniotic membrane graft. Follow-up examinations at 5 days, 2 weeks, 2.5 months, and 5 months after surgery demonstrated closure of the conjunctival defect. The author concludes that amniotic membrane may be useful for the treatment of hydroxyapatite orbital implant exposures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506427     DOI: 10.1097/01.IOP.0000087029.00333.C2

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

1.  Amniotic membrane graft to reconstruct divided nevi of eyelids.

Authors:  Kasturi Bhattacharjee; Manpreet Singh; Harsha Bhattacharjee
Journal:  BMJ Case Rep       Date:  2015-05-24

2.  Effect of basic fibroblast growth factor (bFGF) on the treatment of exposure of the orbital implants.

Authors:  Hong-guang Cui; Hui-yan Li
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

3.  Complications of orbital endoimplantation in the Eye Clinic of the Lithuanian University of Health Sciences.

Authors:  Raimonda Piškinienė; Mantas Banevičius
Journal:  Acta Med Litu       Date:  2017

4.  Reconstruction with umbilical amnion following ocular evisceration: A case study.

Authors:  Lisa S Bunin
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-01

5.  Clinical Results of the Use of Amniotic Membrane Transplantation Alone or in Combination with Adjuvant Therapies in Conjunctival Fornix Reconstruction.

Authors:  Yasemin Aslan Katırcıoğlu; Ahmet Kaderli; Evin Şingar Özdemir; Firdevs Örnek
Journal:  Turk J Ophthalmol       Date:  2022-08-25

6.  Use of extraocular muscle flaps in the correction of orbital implant exposure.

Authors:  Hsueh-Yen Chu; Yi-Lin Liao; Yueh-Ju Tsai; Yen-Chang Chu; Shu-Ya Wu; Lih Ma
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.